Surgery Partners, Inc. (SGRY): Entry into a Material Definitive Agreement

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal Revised transaction with HealthSpan Partners of $25 per share, representing an enterprise value of up to approximately $6.0 billion If the transactio

Event · M&A · definitive agreement
Role
target
Counterparty
HealthSpan Partners
Price per share
$25.00 per share
Consideration
cash
Deal value
$6.0 billion
Expected close
first quarter of 2027

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 9, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 2:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$SGRY
Bullish
high confidence
Mentioned
$SGRY
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SGRYBullishHigh
01

Why it matters

The amendment improves the cash component and adds a ticking fee, making the deal more attractive to shareholders and likely triggering a price rally.

02

Market read

The amended deal terms provide a clear premium, likely prompting a short‑term price increase and influencing healthcare M&A sentiment.

03

What to watch

Potential impact of the third‑party $28 offer and Bain Capital's roll‑over may affect post‑deal ownership dynamics.

Relevance 6/10Novelty 9/10Timing: today

Background

Surgery Partners (NASDAQ:SGRY) operates short‑stay surgical facilities. The company had previously agreed to be acquired by HealthSpan Partners, an affiliate of Bon Secours Mercy Health.

Company-level read

Ticker impact

$SGRYBullishHigh confidence
Context

Surgery Partners announced an amended merger agreement with HealthSpan Partners, raising cash consideration to $25 per share and adding a ticking fee up to $1.61 per share.

Expected impact

upward pressure as the market prices in the higher cash consideration and ticking fee.

Evidence & confidence

Merger arbitrage traders will bid the stock closer to the cash offer, especially given the clear premium and limited upside for dissenting shareholders.

Market effects

Consolidation in outpatient surgical facilities may pressure peers' valuations.

U.S. healthcare M&A activity could see heightened investor interest.

Limited to U.S. healthcare sector; no broad market effect.

Counterpoint

If the merger faces regulatory delays, the stock could fall below current levels.

Key entities

  • Surgery Partners, Inc.

    Target of the merger, listed on NASDAQ.

  • HealthSpan Partners

    Acquiring entity, affiliate of BSMH.

  • Bain Capital Private Equity

    Largest shareholder, rolling over shares.

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re